BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed AQST catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:3dbf6886137afdd01452@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270316
DTEND;VALUE=DATE:20270317
SUMMARY:AQST PDUFA (company-disclosed): PDUFA March 16\, 2027 - Aquestive T
 herapeutics\, Inc.
DESCRIPTION:PDUFA March 16\, 2027 - Aquestive Therapeutics\, Inc.\nConfiden
 ce: company-disclosed\nTicker AQST (confidence 1.0)\nSource: https://www.s
 ec.gov/Archives/edgar/data/1398733/000139873326000079/jefferiesglobalhealt
 hcar.htm\nScheduling/reference data from public records\; dates can move. 
 Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1398733/000139873326000079/jeff
 eriesglobalhealthcar.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
BEGIN:VEVENT
UID:9f4314ec45a81baa3f89@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260130
DTEND;VALUE=DATE:20260131
SUMMARY:AQST CRL: dibutepinephrine sublingual film
DESCRIPTION:CRL 2026-01-30: Aquestive Therapeutics Inc. NDA 219870 (dibutep
 inephrine sublingual film)\nConfidence: confirmed\nTicker AQST (confidence
  0.9)\nSource: https://download.open.fda.gov/crl/CRL_NDA219870_20260130.pd
 f\nScheduling/reference data from public records\; dates can move. Not inv
 estment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://download.open.fda.gov/crl/CRL_NDA219870_20260130.pdf
CATEGORIES:crl,confirmed
END:VEVENT
END:VCALENDAR
